GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to ...

Despite S&P 500 concentration in mega caps, overlooked "losers" present opportunities for investors. Read about five stock ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

Nektar Therapeutics (NASDAQ: NKTR) today announced that, on February 20, 2026, the Organization and Compensation Committee ...

The franchise and transition tag deadline is upon us. But Breece Hall and the Jets still have not agreed to a long-term contract. The Jets will have until 4 p.m. on Tuesday to place either the ...

QuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs, and Endpoint AI solutions, today announced its financial results for ...

Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...

A research collaboration between TAL, the Digital Health Cooperative Research Centre (DHCRC), the University of Sydney, and Workcom is assessing a co-designed digital platform for how life insurers in ...

CorMedix Inc. (NASDAQ:CRMD) Q4 2025 Earnings Call Transcript March 5, 2026 CorMedix Inc. misses on earnings expectations. Reported EPS is $0.1493 EPS, expectations were $0.86. Operator: Good morning, ...

Niagen Bioscience Inc (NASDAQ:NAGE) Q4 2025 Earnings Call Transcript March 4, 2026 Niagen Bioscience Inc beats earnings expectations. Reported EPS is $0.05, expectations were $0.02. Operator: Ladies ...

Joseph Todisco EVP and Chief Operating Officer — Elizabeth Masson-Hurlburt EVP and Chief Financial Officer — Susan Blum ...

Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 ...